IPune, Maharashtra, India, Januwari 19 2021 (Wiredrelease) Prudour Pvt. Ltd -: Ngokophando olutsha oluthembekileyo kwi Ukuhanjiswa kweLiposome yeziyobisi (ukuhanjiswa kweziyobisi ngeLiposomes) (2022-2031), inombono omfutshane wobungakanani bemakethi, ubume bejografi kunye neendlela eziphambili ezisekwe kubungakanani kunye nexabiso, uhlalutyo olude lwe-SWOT, izicwangciso zophuhliso, ixabiso le-CAGR yohlalutyo kunye nokukhula. Ngapha koko, ingxelo igxile kwizinto zokukhula ezibonakalayo kunye nemiqobo eyamkelweyo ziinkokheli zentengiso kule marike.
Ingxelo ibandakanya uhlalutyo lwedatha malunga nenqanaba lentengiso, ipateni yokhuphiswano, izibonelelo kunye nezinto ezingalunganga kwiimveliso zeshishini, iintsingiselo zophuhliso, kunye neempawu zobume beshishini lommandla. Umgaqo-nkqubo wophuhliso kunye nezicwangciso zeengcali zethu zophando zisinceda ukuba sibonise abathengi bethu ngohlalutyo olubanzi nolunzulu lwentengiso yeLiposome Drug Delivery (iLiposomes Drug Delivery) yentengiso.
Ulwazi lwephondo lwendawo luya kukunceda ekugxileni kuzo zonke iindawo eziqhuba kakuhle. Uphononongo lophando luphuma njengokudityaniswa kwezikhokelo eziluncedo zabadlali ukukhusela indawo yamandla kwintengiso. Abavelisi basebenzisa iindlela ngeendlela zokunyusa isabelo sentengiso seemveliso zabo. Le ngxelo ngaphezulu ijolise ngakumbi kushishino lwangoku kunye neentloko zanamhlanje, iintloko zendlela eziza kubakho, kunye neendlela ezivulekileyo zokungena kwintengiso yeLiposome Drug Delivery (iLiposomes Delivery).
Inzuzo yokucela iSampula yePhepha leNgxelo yeFree ngaphambi kokuthenga
- Intshayelelo emfutshane kwingxelo yophando kunye nesishwankathelo sophando.
Inkqubo yeemarike esekwe kwindlela yokuqala kunye nesekondari.
Inkcazo yemizobo yohlalutyo olubanzi nolwengingqi
-Imifanekiso ekhethiweyo yokuqonda kweemarike kunye neendlela.
-Yazi abadlali abaphambili kwimarike ngohlalutyo lwengeniso.
Eminye imiba ephambili yeLiposome yokuhanjiswa kweziyobisi (ukuhanjiswa kweLiposomes kweziyobisi) Ingxelo yentengiso ibonisa ukuba
Isahluko 1: Iimbalasane zeNtengiso: Inkcazo yeMveliso, Uhlobo, ukuSebenzisa ukuphela kunye neNkqubo
Isahluko 2: Isishwankathelo seShishini
2.1 Inkcazo yemakethi
Ububanzi beLiposome yokuhanjiswa kweziyobisi (ukuhanjiswa kweziyobisi ngeLiposomes)
Isahluko 3: Inkqubo yoPhando
3.1 Indlela yokusebenza
3.2 Iindlela zokuqokelela idatha
3.3 Iindlela zokuhlalutya
3.4 Vavanya kwaye uthethelele iindlela zokukhetha
3.5 Ukubhala indlela eyomeleleyo
Isahluko 4: Imibuzo ebuzwa rhoqo kwi-Liposome yokuhanjiswa kweziyobisi (Indlela yokuhanjiswa kweziyobisi yiLiposomes)
4.1 Uthini umda kwaye Mkhulu kangakanani ukuhanjiswa kweLiposome yeziyobisi (ukuhanjiswa kweLiposomes iziyobisi)?
4.2 Lisebenza njani iqhinga lokushishina kwiLiposome Ukuhanjiswa kweziyobisi (ukuhanjiswa kweLiposomes iziyobisi) kwintengiso yophuhliso lwexesha elizayo?
4.3 Yeyiphi eyona mingeni iphambili kwimarike yeLiposome yokuhanjiswa kweziyobisi (iLiposomes Ukuhanjiswa kweziyobisi) ukuya ku-2031?
4.4 Yeyiphi imimandla ehamba kwindawo yentengiso ye-2021 yeLiposome yokuhanjiswa kweziyobisi (ukuhanjiswa kweeLiposomes iziyobisi)?
4.5 Ngowama-2021, ngowuphi ummandla olinga ukuthengiswa kweLiposome Drug Delivery (iLiposomes Drug Delivery) yentengiso ngokubhekisele kwintengiso esebenzayo kunye noqikelelo lwengeniso?
4.6 Ngoobani abarhwebo abaphambili be-CAGR nabadlala phambili kwimakethi yeLiposome Drug Delivery (iLiposomes Delivery Drug)?
4.7 Zeziphi iziphumo eziphambili ezingama-2021 zohlalutyo lwe-SWOT noPorter?
Isahluko 5: Ushwankathelo lwecandelo
Isishwankathelo sendawo yemveliso:
5.1.1 Ngohlobo lwemveliso, ukuhanjiswa kweLiposome iziyobisi (ukuhanjiswa kweLiposomes iziyobisi) Icandelo lentengiso kunye ne-CAGR ephezulu yahlulwe yaba yiLiposomal Doxorubicin, iLiposomal Amphoteracin B, iLiposomal Paclitaxel, enye
5.2 Amagqabantshintshi ngesicelo
5.2.1 Ngokwe-synopsis yezicelo ezifikelela kunyango losulelo lomngundo, umhlaza kunye nonyango lwethumba, okunye
5.3 Uhlalutyo loMmandla:
Iinkampani ezisehlabathini ezijongana nale marike ikakhulu zijolise kwimimandla elandelayo.
-Mntla Melika (Imimandla engaphantsi: i-USA, Canada neMexico, njl.
-Asia-Pacific (Imimandla engaphantsi: China, Japan, Korea, India, kunye ne-mpuma ye-Asia)
-Mbindi Mpuma kunye ne-Afrika (Imimandla engaphantsi: Saudi Arabia, i-UAE, i-Egypt, iTurkey, iNigeria, noMzantsi Afrika)
-IYurophu (Imimandla engaphantsi: EJamani, eFrance, e-UK, eRashiya, nase-Italiya)
-Umzantsi Melika (Imimandla engaphantsi: iBrazil, iArgentina, iColumbia, njl.
Isahluko 6: Uphando lwe-Snapshot:
2015-2020: Ixesha leMbali
2021: Unyaka weSiseko
2022-2031: Ixesha lexesha
Isahluko 7: # Covid_19 Uhlalutyo lwempembelelo
Kwi-2019, sonke siyazi ukuba Esi sifo sisasazeke phantse kuwo onke amazwe / imimandla engqonge umhlaba kunye noMbutho wezeMpilo weHlabathi usibhengeza ngongxamiseko lwempilo yoluntu. Le ngxelo igubungela uhlalutyo lwe-COVID-19 lwefuthe kuyo yonke imiba yokuhanjiswa kweziyobisi yiLiposome (ukuhanjiswa kwamachiza eLiposomes) iMarke njengenkqubo yokuvelisa ngenxa yengxaki yemali kwihlabathi liphela, uMveliso kunye noThutho. Ukuqhambuka kwe-COVID-19 kuzise iziphumo ekunciphiseni okukhulu kwempahla yokuhambisa; ukuguquguquka kwemarike yemasheya; ukuwa kwethemba lokushishina, ukothuka phakathi kwabantu, kunye nokungaqiniseki ngekamva. Oku kulithintele ibango lokuHanjiswa kweziyobisi zeLiposome (ukuhanjiswa kweeLiposomes).
Isicelo soHlalutyo lwe-Impact ye-Covid-19 kwiLiposome yokuhanjiswa kweziyobisi https://market.us/request-covid-19/?report_id=12926
Isahluko 8: Ukhuphiswano lweNdawo
Le marike inokhuphiswano olukhulu. Ingxelo inikezela ngeenkcukacha ezinyanzelekileyo kubungakanani babathengisi abaziwayo kwaye ingumthombo obalulekileyo wesikhokelo kunye neengcebiso kwiinkampani eziphambili kunye nabantu ababandakanyekayo kwimarike.
Abanye babathathi-nxaxheba abaphambili kwimarike yehlabathi yiPacira, iSayensi yaseGiliyadi, iKingond Pharm, iFudan-Zhangjiang, i-Novartis, i-CSPC, i-Spectrum Pharmaceuticals, i-Teva Pharmaceutical, i-Sun Pharmaceutical, i-Shanghai New Asia, i-Luye Pharma, i-Sigma-Tau Group kunye no-Johnson no-Johnson .
Amabali aPhezulu avela eturbonews: https://eturbonews.com/
Ukuqonda okunxulumene noko:
Lo mxholo upapashwe nguPrudour Pvt. Inkampani ye-Ltd. ISebe leendaba leWiredRelease alibandakanyekanga ekwenziweni kwalo mxholo. Ngemibuzo malunga nenkonzo yokukhutshwa kweendaba, nceda usifikelele apha [imeyile ikhuselwe].